Shares of GSK PLC GSK rose 1.02% to £14.30 Wednesday, on what proved to be an all-around positive trading session for the ...

Tezepelumab, a monoclonal antibody targeting TSLP approved for add-on severe asthma treatment in 2021, had been associated ...

This Philly-based company is using AI to predict which medical research can lead to profitable drugs and therapies Clarivate ...

The pharma company said it expects more approvals through the year following positive results from a Phase 3 trial.

GSK will incorporate the findings into messaging that depemokimab patients will adhere to treatment better, ensuring better ...

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary ...

The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children are vaccinated against all strains.

Started in 2007, Gabii sa Kabilin — which is “night of heritage” in Cebuano — is an annual cultural event that aims to promote and preserve Cebu’s rich culture, history, and architectural heritage.

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

A kidnapped child, a husband with a double life, a treacherous murder plot unraveled when the police arrive at the perfect ...

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...

GSK acquires Boston Pharmaceuticals' efimosfermin for up to $2 billion, targeting liver diseases like MASH and ALD.